Jilin Jian Yisheng Pharmaceutical Co., Ltd. (002566) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Jilin Jian Yisheng Pharmaceutical Co., Ltd.

Why is Jilin Jian Yisheng Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -5.54% and Operating profit at -32.02% over the last 5 years

Flat results in Mar 26

NET PROFIT(HY) At CNY 16.64 MM has Grown at -24.3%
ROCE(HY) Lowest at 1.48%
INTEREST(Q) At CNY 3.09 MM has Grown at 14.39%

With ROE of 1.56%, it has a fair valuation with a 0.61 Price to Book Value

Over the past year, while the stock has generated a return of -19.79%, its profits have risen by 2.5% ; the PEG ratio of the company is 16
At the current price, the company has a high dividend yield of 1.2

Below par performance in long term as well as near term

Along with generating -19.79% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Jilin Jian Yisheng Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Jilin Jian Yisheng Pharmaceutical Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Jilin Jian Yisheng Pharmaceutical Co., Ltd.

-20.98%

-0.09

30.63%

China Shanghai Composite

16.78%

1.40

13.75%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-5.54%

EBIT Growth (5y)

-32.02%

EBIT to Interest (avg)

5.93

Debt to EBITDA (avg)

0.38

Net Debt to Equity (avg)

-0.04

Sales to Capital Employed (avg)

0.26

Tax Ratio

15.50%

Dividend Payout Ratio

91.32%

Pledged Shares

Institutional Holding

ROCE (avg)

3.70%

ROE (avg)

3.80%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.61

EV to EBIT

79.91

EV to EBITDA

25.70

EV to Capital Employed

0.58

EV to Sales

1.84

PEG Ratio

16.00

Dividend Yield

1.19%

ROCE (Latest)

0.73%

ROE (Latest)

1.56%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -4.32% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -7.38 %

NET SALES(Q)

Highest at CNY 174.34 MM

PRE-TAX PROFIT(Q)

Highest at CNY 15.91 MM

NET PROFIT(Q)

Highest at CNY 13.57 MM

EPS(Q)

Highest at CNY 0.05

-10What is not working for the Company

NET PROFIT(HY)

At CNY 16.64 MM has Grown at -24.3%

ROCE(HY)

Lowest at 1.48%

INTEREST(Q)

At CNY 3.09 MM has Grown at 14.39%

INTEREST COVERAGE RATIO(Q)

Lowest at 254.76

OPERATING PROFIT(Q)

Lowest at CNY 7.87 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 4.51 %

Here's what is working for Jilin Jian Yisheng Pharmaceutical Co., Ltd.

Net Sales

Highest at CNY 174.34 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 15.91 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

At CNY 15.91 MM has Grown at 87.56%

over average net sales of the previous four periods of CNY 8.48 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 13.57 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Profit

At CNY 13.57 MM has Grown at 66.33%

over average net sales of the previous four periods of CNY 8.16 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.05

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Debt-Equity Ratio

Lowest at -7.38 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -4.32% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Jilin Jian Yisheng Pharmaceutical Co., Ltd.

Interest

At CNY 3.09 MM has Grown at 14.39%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 254.76

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit

Lowest at CNY 7.87 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 4.51 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales